Ofengeim Dimitry, Giagtzoglou Nikolaos, Huh Dann, Zou Chengyu, Yuan Junying
Biogen, Neurology, 115 Broadway Street, Cambridge, MA 02142, USA.
Biogen, Neurology, 115 Broadway Street, Cambridge, MA 02142, USA.
Trends Mol Med. 2017 Jun;23(6):563-576. doi: 10.1016/j.molmed.2017.04.006. Epub 2017 May 10.
Single-cell RNA sequencing (scRNA-seq) is an exciting new technology allowing the analysis of transcriptomes from individual cells, and is ideally suited to address the inherent complexity and dynamics of the central nervous system. scRNA-seq has already been applied to the study of molecular taxonomy of the brain. These works have paved the way to expanding our understanding of the nervous system and provide insights into cellular susceptibilities and molecular mechanisms in neurological and neurodegenerative diseases. We discuss recent progress and challenges in applying this technology to advance our understanding of the brain. We advocate the application of scRNA-seq in the discovery of targets and biomarkers as a new approach in developing novel therapeutics for the treatment of neurodegenerative diseases.
单细胞RNA测序(scRNA-seq)是一项令人兴奋的新技术,它能够分析单个细胞的转录组,非常适合用于解决中枢神经系统固有的复杂性和动态性。scRNA-seq已被应用于大脑分子分类学的研究。这些工作为扩展我们对神经系统的理解铺平了道路,并为神经和神经退行性疾病中的细胞易感性和分子机制提供了见解。我们讨论了应用该技术推进我们对大脑理解方面的最新进展和挑战。我们提倡将scRNA-seq应用于发现靶点和生物标志物,作为开发治疗神经退行性疾病新疗法的一种新方法。